Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
企業コードRPID
会社名Rapid Micro Biosystems Inc
上場日Jul 15, 2021
最高経営責任者「CEO」Mr. Robert (Rob) Spignesi
従業員数163
証券種類Ordinary Share
決算期末Jul 15
本社所在地25 Hartwell Avenue
都市LEXINGTON
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号02421
電話番号19783493200
ウェブサイトhttps://www.rapidmicrobio.com/
企業コードRPID
上場日Jul 15, 2021
最高経営責任者「CEO」Mr. Robert (Rob) Spignesi
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし